Chemed Corp reports results for the quarter ended June 30 - Earnings Summary

Chemed

29/07/2026 01:28

Chemed Corp CHE.N reported quarterly adjusted earnings of $6.06​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $4.27.  The mean expectation of four analysts for the quarter was for earnings of $5.60 per share. Wall Street expected results to range from $5.41  to $5.80 per share.
Revenue rose 8.8% to $673.25 million from a year ago; analysts expected $665.04 million. 
Chemed Corp's reported EPS for the quarter was $5.13​.
The company reported quarterly net income of $67.7 million.
Chemed Corp shares had risen by 9.4% this quarter and gained 19.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.5% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the healthcare facilities & services peer group is also "buy" 
Wall Street's median 12-month price target for Chemed Corp is $475.00, about 9% below its last closing price of $517.63
This summary was machine generated from LSEG data July 29 at 12:28 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
5.60
6.06
Beat
Mar. 31 2026 
5.30
5.65
Beat
Dec. 31 2025 
7.07
6.42
Missed
Sep. 30 2025 
5.37
5.27
Missed